How Does tPA Work for Ischemic Strokes?
Tissue plasminogen activator (tPA) is a medication used in the treatment of ischemic strokes, which occur when a blockage, typically a blood clot, obstructs blood flow to a part of the brain. tPA is a clot-busting drug that works by promoting the dissolution of the clot, thereby restoring blood flow to the affected area of the brain. This treatment is time-sensitive and most effective when administered as quickly as possible after the onset of stroke symptoms.
What is a stroke?
Per the Mayo Clinic, “An ischemic stroke occurs when the blood supply to part of the brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients. Brain cells begin to die in minutes. A stroke is a medical emergency, and prompt treatment is crucial. Early action can reduce brain damage and other complications.”
What are the symptoms of stroke?
Remember the acronym FAST to help identify the signs of a stroke.
F – Face Drooping: One side of the face may droop or feel numb. Ask the person to smile, and if one side of the smile is uneven or lopsided, it could be a sign of a stroke.
A – Arm Weakness: One arm may become weak or numb. Ask the person to raise both arms, and if one arm drifts downward or is noticeably weaker, it could be a sign of a stroke.
S – Speech Difficulty: Speech may become slurred or difficult to understand. Ask the person to repeat a simple sentence, and if their speech is garbled or incoherent, it could be a sign of a stroke.
T – Time to Call 911: If you observe any of these signs, even if they seem to improve or disappear, it’s crucial to call 911 or seek emergency medical help immediately. Time is of the essence when it comes to stroke treatment.
Additional signs and symptoms of stroke include:
- Sudden numbness or weakness. This can affect the face, arm, or leg, especially on one side of the body.
- Sudden confusion or trouble understanding. Individuals may have difficulty speaking or comprehending language.
- Sudden trouble seeing. Blurred or double vision, or sudden vision loss in one or both eyes, can occur.
- Sudden trouble walking. Loss of balance, dizziness, or difficulty walking may be experienced.
- Sudden severe headache. A sudden and severe headache, often described as the worst headache of one’s life, can occur in hemorrhagic strokes.
- Difficulty swallowing. Some individuals may experience difficulty swallowing or a sudden onset of drooling.
It’s important to note that the symptoms of a stroke can vary depending on the individual and the location of the brain affected. Some people may experience a combination of these symptoms, while others may have only one or a few. Additionally, the severity of the symptoms can also vary.
If you suspect that someone is experiencing a stroke, do not wait for the symptoms to improve. Act quickly and call 911 or seek emergency medical attention. Early intervention and treatment are essential for minimizing the impact of a stroke and improving the chances of a successful recovery.
What is tPA?
Tissue plasminogen activator, or tPA, was approved by the FDA in the 1990s as a treatment for acute stroke. Per the National Institute of Health (NIH):
Known by the generic name alteplase and marketed as Activase® (Genentech), tPA is given to patients through an IV in the arm, and it works by dissolving blood clots that block blood flow to the brain. When administered quickly after stroke onset (within three hours, as approved by the FDA), tPA helps to restore blood flow to brain regions affected by a stroke, thereby limiting the risk of damage and functional impairment.
How does tPA work?
Here’s how tPA works and its role in stroke treatment:
- Clot dissolution mechanism. tPA is a naturally occurring enzyme found in the body. When administered as a medication, it binds to fibrin, a protein present in blood clots. This binding triggers a series of biochemical reactions that convert plasminogen, an inactive precursor, into plasmin, an enzyme responsible for breaking down fibrin.
- Restoration of blood flow. By promoting the breakdown of fibrin, tPA helps to dissolve the blood clot that is blocking blood flow to a part of the brain. Once the clot is dissolved, blood flow can be restored to the affected area, reducing the potential damage to brain tissue.
- Time sensitivity: It is crucial to note that the effectiveness of tPA is time-dependent. It is most beneficial when administered as quickly as possible after the onset of stroke symptoms. The window for tPA administration is typically within the first few hours of symptom onset, up to three hours in many cases. Beyond this time frame, the risks associated with tPA, such as bleeding complications, may outweigh its potential benefits.
- Eligibility and risk assessment. Not all ischemic stroke patients are eligible for tPA treatment. Medical professionals carefully assess each patient’s medical history, the time of symptom onset, and other factors to determine whether tPA is appropriate. Certain medical conditions, recent surgeries, and specific medications may influence the decision to use tPA.
- Monitoring and precautions. tPA treatment requires close monitoring of the patient’s condition. There is a risk of bleeding, particularly in the brain, as the medication can also affect other blood vessels. Medical professionals must carefully balance the potential benefits of clot dissolution with the risk of bleeding complications.
- Combined treatments. In some cases, tPA treatment may be followed by additional interventions, such as mechanical thrombectomy, a procedure that involves physically removing the clot from the blood vessel. This combined approach aims to maximize the restoration of blood flow and minimize the extent of brain damage.
Why is it so important to administer tPA immediately?
Administering tPA (tissue plasminogen activator) as soon as possible after the onset of stroke symptoms is crucial for several important reasons.
Ischemic strokes occur when a blood clot or other blockage restricts blood flow to a part of the brain. Brain cells are highly sensitive to oxygen and nutrient deprivation, and without prompt intervention, they can start to die within minutes. Administering tPA quickly helps dissolve the clot, restore blood flow, and prevent or minimize irreversible brain damage.
The effectiveness of tPA diminishes over time. The medication is most successful when it is administered within a specific time frame after the onset of symptoms. The sooner tPA is given, the higher the likelihood of successfully dissolving the clot and restoring blood flow to the brain.
Research has shown that early administration of tPA is associated with better patient outcomes. Stroke patients who receive tPA within the recommended time window are more likely to experience reduced disability, shorter hospital stays, and a higher likelihood of returning to independent living.
Administering tPA promptly helps minimize the extent of brain damage caused by the lack of blood flow. By restoring blood circulation to the affected brain region, tPA helps salvage brain tissue that is at risk of irreversible injury. This can lead to a better overall recovery and quality of life for stroke survivors.
Research and medical advancements are exploring the possibility of extending the treatment window for tPA in select cases. However, the established time window for tPA administration (usually up to three hours from symptom onset) remains a critical guideline for maximizing its benefits while minimizing risks.
For ischemic strokes, tPA is one of the few treatments available that can rapidly dissolve clots and restore blood flow. Administering tPA promptly increases the chances of successful clot dissolution and reduces the need for more invasive or complex interventions.
Recovery from a stroke can be a challenging and time-intensive process. Administering tPA early can contribute to a more rapid recovery, helping patients regain lost functions and abilities more quickly.
If you or a loved one suffered injury or disability from the delayed treatment of a stroke, the attorneys at Garcia & Artigliere want to help. With a combined 150 years of experience, our attorneys have the experience and resources you need for your case. To schedule a consultation, simply call our offices or fill out our contact form and tell us a little bit about yourself. We serve clients throughout the country from our offices in Louisville, Los Angeles, Long Beach, Phoenix, and New Orleans. Our services are available in both English and Spanish.
Se habla español.
Stephen M. Garcia represents victims of elder and nursing home abuse and is known as one of the leading civil litigators in the country. He is Senior Partner at Garcia & Artigliere, where the firm’s practice is focused on elder abuse, nursing home abuse, and wrongful death of the elderly.
Find out more about Stephen M. Garcia